ConductScience.org, home

Paper · 35600577

Latest Advancements on Combating Obesity by Targeting Human Brown/Beige Adipose Tissues.

Pan R and 1 other. Front Endocrinol (Lausanne), 2022. Cited by 9 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Latest Advancements on Combating Obesity by Targeting Human Brown/Beige Adipose Tissues. Papers, record 35600577. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35600577

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Latest Advancements on Combating Obesity by Targeting Human Brown/Beige Adipose Tissues.
PubMed
Journal
Front Endocrinol (Lausanne)
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.72
iCite
Revised in PubMed
2022-07-28
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pan RRuping
2Chen YYong

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 2Major topic
Metabolic DiseasesMajor topic
Adipose Tissue, Beige
Adipose Tissue, Brown
Humans
Obesity
Positron Emission Tomography Computed Tomography

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References55

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133,013,706Metabolic Improvement via Enhancing Thermogenic Fat-Mediated Non-shivering Thermogenesis: From Rodents to Humans.Front Endocrinol (Lausanne)2020https://conductscience.org/library/papers/33013706PubMed
230,325,968Cardiovascular risk profile in individuals initiating treatment for overactive bladder - Challenges and learnings for comparative analysis using linked claims and electronic medical record databases.PLoS One2018https://conductscience.org/library/papers/30325968PubMed
330,661,513
Vibegron (RVT-901/MK-4618/KRP-114V) Administered Once Daily as Monotherapy or Concomitantly with Tolterodine in Patients with an Overactive Bladder: A Multicenter, Phase IIb, Randomized, Double-blind, Controlled Trial.
Eur Urol2019https://conductscience.org/library/papers/30661513PubMed
434,100,382β3-Adrenergic receptors regulate human brown/beige adipocyte lipolysis and thermogenesis.JCI Insight2021https://conductscience.org/library/papers/34100382PubMed
532,435,180Involvement of Secretin in the Control of Cell Survival and Synaptic Plasticity in the Central Nervous System.Front Neurosci2020https://conductscience.org/library/papers/32435180PubMed
633,398,160Brown adipose tissue is associated with cardiometabolic health.Nat Med2021https://conductscience.org/library/papers/33398160PubMed
734,048,700Lipolysis drives expression of the constitutively active receptor GPR3 to induce adipose thermogenesis.Cell2021https://conductscience.org/library/papers/34048700PubMed
830,411,311Vibegron: First Global Approval.Drugs2018https://conductscience.org/library/papers/30411311PubMed
9408,145Plasma secretin concentration in man: effect of intraduodenal glucose, fat, amino acids, ethanol, HCl, or ingestion of a meal.Eur J Clin Invest1977https://conductscience.org/library/papers/408145PubMed
1030,496,126FGF9 inhibits browning program of white adipocytes and associates with human obesity.J Mol Endocrinol2019https://conductscience.org/library/papers/30496126PubMed

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
41,497,271Significance of neuroendocrine systems and the gut-brain axis (GBA) in the regulation of obesity.PeerJ2026https://conductscience.org/library/papers/41497271PubMed
38,577,419Dietary kaempferol exerts anti-obesity effects by inducing the browing of white adipocytes via the AMPK/SIRT1/PGC-1α signaling pathway.Curr Res Food Sci2024https://conductscience.org/library/papers/38577419PubMed
37,948,566Use of FGF21 analogs for the treatment of metabolic disorders: a systematic review and meta-analysis.Arch Endocrinol Metab2023https://conductscience.org/library/papers/37948566PubMed
37,680,891Latest advances in the regulatory genes of adipocyte thermogenesis.Front Endocrinol (Lausanne)2023https://conductscience.org/library/papers/37680891PubMed
37,435,495Treatment of obesity-related diabetes: significance of thermogenic adipose tissue and targetable receptors.Front Pharmacol2023https://conductscience.org/library/papers/37435495PubMed
37,110,178High-Fat-Diet Suppressed Ketone Body Utilization for Lipogenic Pathway in Brown Adipose Tissues.Metabolites2023https://conductscience.org/library/papers/37110178PubMed
35,806,493LncRNA-Mediated Adipogenesis in Different Adipocytes.Int J Mol Sci2022https://conductscience.org/library/papers/35806493PubMed

Genes38

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35600577

GET https://conductscience.org/api/papers/v1/35600577/references?page=2